Clopidogrel Bisulfate

硫酸氢氯吡格雷

Report date: 2023/02/22 14:52:48
NME

Base Information

Drug NameClopidogrel Bisulfate
Drug Alias NameClopidogrel hydrogen sulfate氯吡格雷硫酸氢盐氯吡格雷ClopidogrelumClopidogrel hydrogen sulphate +[19] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPurinergic receptor P2Y12 antagonists
TargetsPurinergic receptor P2Y12
Therapy Area/IndicationsIschemic StrokeFastingIschemia +[33] 
Global Approved IndicationsPeripheral Vascular DiseasesPeripheral Arterial DiseaseST Elevation Myocardial Infarction +[12] 
Approved Indications in ChinaPeripheral Arterial DiseaseST Elevation Myocardial InfarctionNon-ST Elevated Myocardial Infarction +[11] 
Original Approved Country/TerritoryUnited States
Original Approved Date1997/11/17
Country/TerritoryCzechiaBelgiumCanada +[42] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Sao PauloSanofiKafrelsheikh University +[8] 
Inactive CompaniesHanmi Pharmaceutical Co LtdBristol Myers Squibb SrlcompanyUniversity Of California San Francisco +[23] 
Active IndicationsIschemic StrokePeripheral Vascular DiseasesPeripheral Arterial Disease +[15] 
Inactive IndicationsFastingIschemiaHemorrhage +[18] 

Other Information

ATC CodeB01AC04
Related LinksWikipediaDrugBankKEGG